Survey reveals less than half of Americans plan to get flu shot this season

A survey conducted by the National Foundation for Infectious Diseases (NFID) revealed that only 49 percent of polled U.S. adults plan to get a flu shot this season, CNBC reports.
The data shows that 1 in 5 respondents at higher risk for influenza-related complications reported that they do not plan to get the annual vaccine this season. People over 65 years old, pregnant people, patients with underlying conditions, and children under five face a significant risk of severe outcomes if infected with the flu, per the Centers for Disease Control and Prevention.
The NFID survey found that while nearly 70 percent of people agreed that the annual flu shot was the best way to prevent fatal influenza infections, many are still electing not to get the vaccine this year. CNBC reports that 58 percent of the Americans surveyed plan to wear masks at least part of the time to protect themselves during flu season, which exceeds the number who plan to get the shot.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Per the NFID survey, some of the top reasons for not getting the vaccine include believing that the flu shot is ineffective and concerns over potential side effects.
"With COVID, people have forgotten about influenza," said William Schaffner, medical director of NFID, at an NFID conference on Tuesday. "This is another serious winter respiratory virus, it can do bad damage to you. The key to prevention is vaccination."
The survey polled 1,005 adult respondents throughout the United States and was conducted via phone and web between Aug. 11 and 15. The overall margin of error is +/- 4.2 percentage points.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Theara Coleman has worked as a staff writer at The Week since September 2022. She frequently writes about technology, education, literature and general news. She was previously a contributing writer and assistant editor at Honeysuckle Magazine, where she covered racial politics and cannabis industry news.
-
Why some people remember dreams and others don't
Under The Radar Age, attitude and weather all play a part in dream recall
By Chas Newkey-Burden, The Week UK Published
-
The Week contest: Hotel seal
Puzzles and Quizzes
By The Week US Published
-
New FBI Director Kash Patel could profit heavily from foreign interests
The Explainer Patel holds more than $1 million in Chinese fashion company Shein
By Justin Klawans, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
Oysters could help combat antibiotic resistance
Under the radar The mollusk shows infection-fighting abilities
By Devika Rao, The Week US Published
-
How Trump's executive orders are threatening scientific research
In the spotlight Agencies are purging important health information
By Devika Rao, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
Why is the FDA slow to ban food additives?
Today's big question A legal loophole lets things slide
By Devika Rao, The Week US Published